The Scientific and Research Team at Valo Therapeutics focuses on developing innovative immunooncology therapies by engineering tumour antigen-coated oncolytic viruses. The team conducts advanced research, validates antigen targets, and manages laboratory operations to translate scientific findings into effective therapeutic vaccines.